In the course of the 24 months of BioAXOS, extensive production engineering work was conducted, pre-commercial regulatory actions and clinical trials preparations were carried out and preliminary product and market development partnerships were established.
In the area of production engineering, multiple pilot plant batches were produced, analysed and used for fine tuning the process design. Laboratory resources were upgraded, to enable the carrying out of analysis in house, thereby shortening turn-around times for reporting on batch outputs, and enabling consistency of analysis methods.
Regarding regulatory pathways for dietary fiber in EU and USA markets, and in human and animal sectors, a comprehensive analysis of the regulatory contexts was conducted and numerous experts in the area were consulted. The team continues to monitor developments in the regulatory landscape. Final dossiers for regulatory actions will be completed in parallel with completion of the production process, as the product characteristics are in part dependent on the process.
Preliminary work was carried out to establish the best strategy for clinical trials execution.
In depth product and market analysis was performed to create a comprehensive map of comparable dietary fibres (products, characteristics, producers, volumes, pricing, marketing strategies), enabling Pure Fiber position its offerings in an optimal way.
The project team held multiple meetings with experts in the fields of prebiotic research and food manufacturing, with the dual aims of researching the sector and establishing relationships for potential future collaborations.
The team participated in a number of important research and business oriented conferences and trade fairs.
In the latter half of the period all of the key unit operations of the production process were enhanced, improvements were made for odour and appearance, food product ingredient trials were conducted for a number of product types, and certain prebiotic efficacy tests were carried out.
